27 results
424B5
PCSA
Processa Pharmaceuticals Inc
24 Mar 22
Prospectus supplement for primary offering
4:15pm
regarding registrants that file electronically with the SEC at: www.sec.gov.
The information contained on our website and social media channels
8-K
EX-1.1
83nswb5b 9w4avz1i7az
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
8-K
EX-2.1
zq0d4femqg2dsc0onw
5 Oct 17
Heatwurx, Inc Announces Execution of Definitive Asset Purchase Agreement with Promet Therapeutics, LLC
12:00am
8-K
EX-99.5
ydjgpxzhkv8v6z41xu0
20 Feb 15
Senior Secured Loan Agreement
12:00am
10-K
fubs0vtstbmil0h1
27 Mar 14
Annual report
12:00am
424B3
rcswxxu
6 Jun 13
Prospectus supplement
12:00am